Krishna Institute of Medical Sciences Limited
NSE:KIMS.NS
570.15 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,884 | 6,337.97 | 6,058.36 | 6,524.82 | 6,060.29 | 5,759.29 | 5,621.62 | 5,640.72 | 4,955.14 | 3,524.92 | 3,935.68 | 4,117.4 | 4,731.79 | 3,585.38 | 3,606.65 | 4,096.33 | 2,011.01 | 2,662.69 | 1,642.645 | 1,642.645 |
| Cost of Revenue
| 3,002 | 2,891.56 | 2,298.18 | 2,460.76 | 2,339.08 | 4,685.14 | 1,235.09 | 2,094.51 | 1,097.68 | 1,207.36 | 1,432.2 | 1,490.2 | 1,848.55 | 1,336.93 | 1,341.82 | 1,515.89 | 896.76 | 1,161.08 | 755.915 | 755.915 |
| Gross Profit
| 3,882 | 3,446.41 | 3,760.18 | 4,064.06 | 3,721.21 | 1,074.15 | 4,386.53 | 3,546.21 | 3,857.46 | 2,317.56 | 2,503.48 | 2,627.2 | 2,883.24 | 2,248.45 | 2,264.83 | 2,580.44 | 1,114.25 | 1,501.61 | 886.73 | 886.73 |
| Gross Profit Ratio
| 0.564 | 0.544 | 0.621 | 0.623 | 0.614 | 0.187 | 0.78 | 0.629 | 0.778 | 0.657 | 0.636 | 0.638 | 0.609 | 0.627 | 0.628 | 0.63 | 0.554 | 0.564 | 0.54 | 0.54 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 1,791.07 | 0 | 0 | 0 | 93.5 | 0 | 0 | 0 | 251.17 | 0 | 0 | 0 | 17.71 | 492.145 | 492.145 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 197.39 | 0 | 0 | 0 | 111.51 | 0 | 0 | 0 | 32.24 | 0 | 0 | 0 | 28.9 | 16.415 | 16.415 |
| SG&A
| 2,478 | 2,319.71 | 2,288.97 | 2,291.34 | 2,150.57 | 1,988.46 | 2,002.76 | 2,021.89 | 1,652.73 | 205.01 | 1,205.87 | 1,339.41 | 1,446.56 | 283.41 | 0 | 0 | 0 | 46.61 | 508.56 | 508.56 |
| Other Expenses
| 46 | 38.07 | 32.55 | 28.82 | 31.12 | 48.83 | 64.51 | 92.04 | 53.35 | -83.34 | 23.92 | 54.06 | 42.73 | -23.64 | 0.85 | 15.24 | 43.69 | 0 | 0 | 0 |
| Operating Expenses
| 2,478 | 2,319.71 | 2,642.73 | 2,617.41 | 2,473.22 | -203.88 | 3,207.63 | 2,333.08 | 2,780 | 1,195.56 | 1,393.95 | 1,520.81 | 1,617.44 | 1,292.37 | 1,529.98 | 1,331.98 | 926.5 | 1,033.2 | 670.575 | 670.575 |
| Operating Income
| 1,404 | 1,126.7 | 1,148.77 | 1,475.25 | 1,247.99 | 1,326.86 | 1,243.41 | 1,305.17 | 1,077.46 | 989.71 | 1,109.53 | 1,106.39 | 1,265.8 | 852.46 | 735.7 | 1,263.7 | 187.75 | 464.22 | 215.49 | 215.49 |
| Operating Income Ratio
| 0.204 | 0.178 | 0.19 | 0.226 | 0.206 | 0.23 | 0.221 | 0.231 | 0.217 | 0.281 | 0.282 | 0.269 | 0.268 | 0.238 | 0.204 | 0.308 | 0.093 | 0.174 | 0.131 | 0.131 |
| Total Other Income Expenses Net
| -133 | -125.5 | -124.27 | -89.1 | -62.2 | -54.15 | -115.24 | 69.49 | -3.91 | 78.47 | 13.93 | 25.19 | -20.49 | -42.26 | -90.52 | -68.99 | -47.69 | -89.22 | -72.13 | -72.13 |
| Income Before Tax
| 1,271 | 1,001.2 | 1,024.5 | 1,386.15 | 1,185.79 | 1,272.71 | 1,128.17 | 1,374.66 | 1,073.55 | 1,068.18 | 1,123.46 | 1,131.58 | 1,245.31 | 810.2 | 645.18 | 1,194.71 | 140.06 | 375 | 143.36 | 143.36 |
| Income Before Tax Ratio
| 0.185 | 0.158 | 0.169 | 0.212 | 0.196 | 0.221 | 0.201 | 0.244 | 0.217 | 0.303 | 0.285 | 0.275 | 0.263 | 0.226 | 0.179 | 0.292 | 0.07 | 0.141 | 0.087 | 0.087 |
| Income Tax Expense
| 319 | 285.02 | 258.99 | 373.21 | 319.08 | 285.96 | 309.9 | 313.98 | 281.1 | 234.94 | 281.59 | 289.04 | 325.01 | 223.99 | 167.39 | 293.16 | 50.82 | 97.6 | 50.085 | 50.085 |
| Net Income
| 866 | 654.73 | 718.44 | 920.16 | 808 | 932.72 | 759.8 | 971.14 | 699.58 | 806.88 | 811.75 | 817.17 | 891.28 | 578.02 | 487.91 | 834.75 | 111.27 | 286.52 | 89.045 | 89.045 |
| Net Income Ratio
| 0.126 | 0.103 | 0.119 | 0.141 | 0.133 | 0.162 | 0.135 | 0.172 | 0.141 | 0.229 | 0.206 | 0.198 | 0.188 | 0.161 | 0.135 | 0.204 | 0.055 | 0.108 | 0.054 | 0.054 |
| EPS
| 10.82 | 8.18 | 8.98 | 11.5 | 10.1 | 11.66 | 9.49 | 12.14 | 8.74 | 8.91 | 10.14 | 10.34 | 11.48 | 7.62 | 6.55 | 10.99 | 1.46 | 3.81 | 1.24 | 1.24 |
| EPS Diluted
| 10.82 | 8.18 | 8.98 | 11.5 | 10.1 | 11.66 | 9.49 | 12.14 | 8.74 | 8.91 | 10.14 | 10.34 | 11.48 | 7.47 | 6.45 | 10.76 | 1.43 | 3.82 | 1.24 | 1.24 |
| EBITDA
| 1,794 | 1,589.7 | 1,502.53 | 1,801.32 | 1,601.76 | 1,681.17 | 1,576.33 | 1,616.36 | 1,424.98 | 1,292.02 | 1,341.19 | 1,341.85 | 1,479.41 | 1,018.84 | 931.16 | 1,427.8 | 400.86 | 615.54 | 312.695 | 312.695 |
| EBITDA Ratio
| 0.261 | 0.251 | 0.248 | 0.276 | 0.264 | 0.292 | 0.28 | 0.287 | 0.288 | 0.367 | 0.341 | 0.326 | 0.313 | 0.284 | 0.258 | 0.349 | 0.199 | 0.231 | 0.19 | 0.19 |